- China cleared a brain‑computer interface for commercial use.
The National Medical Products Administration gave approval to NEO, a coin‑sized implant developed by NeuraMatrix and Tsinghua University researchers. The device is marketed for patients with spinal‑cord injuries and is now a regulated medical product in China. Approval came after clinical trials demonstrated the ability to translate neural signals into machine commands.
This moves brain‑machine interfacing out of the lab and onto hospital shelves, giving clinicians a tool that was previously only a prototype. It also puts China ahead of competitors like Neuralink in bringing a usable product to market, potentially attracting patients and investors seeking an approved solution.
The clearance is limited to a specific medical niche and does not imply a broader consumer market yet, but it does set a regulatory precedent for future neurotech devices.